• Papers

  more

• [1] Computational studies of the binding modes of A(2A) adenosine receptor antagonists
• [2] [Advances in the study of A2B adenosine receptor antagonists].
• • [3] Mechanistic Study of Human Glucose Transport Mediated by GLUT1
  • [4] Synthesis of NO-NSAID dendritic prodrugs via Passerini reaction: new approach to the design of dendrimer-drug conjugates
  • [5] Docking and Molecular Dynamics Study on the Inhibitory Activity of Novel Inhibitors on Epidermal Growth Factor Receptor (EGFR)
  • [6] Computer-aided de novo ligand design and docking/molecular dynamics study of Vitamin D receptor agonists
  • [7] The discovery of a facile access to the synthesis of NSAID dendritic prodrugs
  • [8] Design, Synthesis, Biological Evaluation, and Structure-Activity Relationship (SAR) Discussion of Dipeptidyl Boronate Proteasome Inhibitors, Part I: Comprehensive Understanding of the SAR of alpha-Amino Acid Boronates
  • [9] Glucose conjugated platinum(II) complex: Antitumor superiority to oxaliplatin, combination effect and mechanism of action.
  • [10] 2-Deoxyglucose conjugated platinum (II) complexes for targeted therapy: design, synthesis, and antitumor activity
  • [11] 3D-pharmacophore models for selective A(2A) and A(2B) adenosine receptor antagonists
  • [12] 3D-pharmacophore model for RXR gamma agonists
  • [13] Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer.
  • [14] Pharmacophore Based Drug Design Approach as a Practical Process in Drug Discovery
  • [15] 3D-QSAR study of corticotropin-releasing factor 1 antagonists and pharmacophore-based drug design
  • [16] 3D Pharmacophore Based Virtual Screening of A(2A) Adenosine Receptor Antagonists
  • [17] Cyanine-based 1-amino-1-deoxyglucose as fluorescent probes for glucose transporter mediated bioimaging
  • [18] A three-dimensional pharmacophore model for RXR alpha agonists
  • [19] Strategies on the Development of Small Molecule Anticancer Drugs for Targeted Therapy
  • [20] Molecular docking study of A(3) adenosine receptor antagonists and pharmacophore-based drug design
  • [21] Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties

• Books

  more

• [1] Qian Mi, Yuru Ma, Ran Liu, Xiangqian Gao, Pengxing Liu, Yi Mi, Xuegang Fu, and QingzhiGao*, 2-Deoxyglucose Conjugated Platinum (II) Complexes for Targeted Therapy: Design, Synthesis, and Antitumor Activity. Journal of Biomolecular Structure & Dynamics, 2015, 30,1-12.
• [2] Hong Li, Xiangqian Gao, Ran Liu, Yu Wang, Menghua Zhang, Zheng Fu, Yi Mi, Yiqiang Wang, Zhi Yao, Qingzhi Gao*, Glucose conjugated platinum(II) complex: Antitumor superiority to oxaliplatin, combination effect and mechanism of action. European Journal of Medicinal Chemistry, 2015, 101, 400-408.
• • [3] Liu, P.; Lu, Y.; Li, H.; Gao, X.; Liu, R.; Zhang-Negrerie, D.; Shi, Y.; Wang, Y.; Wang, S.; Gao, Q. Highly Water-soluble Platinum(II) Complex as GLUT Substrate for Targeted Therapy: Improved Anticancer Efficacy and Ttransporter-mediated Cytotoxic Properties. Chem. Commun. 2013, 49, 2421.
  • [4] Lu, Y.; Gao, X.; Wu, M.; Zhang-Negrerie, D.; Gao, Q. Strategies on the Development of Small Molecule Anticancer Drugs for Targeted Therapy. Mini-Rev in Med. Chem. 2011, 11, 611.
  • [5] Qingzhi Gao, Q.; Yang, L.; Zhu, Y. Pharmacophore Based Drug Design Approach as a Practical Process in Drug Discovery Current. Comput-Aided Drug Design 2010, 6, 37.
  • [6] Ye, Y.; Wei, J.; Dai, X.; Gao, Q. Computational Studies of the Binding Modes of A2A Adenosine Receptor Antagonists. Amino Acids 2008, 35, 389.
  • [7] Wei, J.; Wang, S.; Gao, S.; Dai X.; Qingzhi Gao, Q. 3D-Pharmacophore Models for Selective A2A and A2B Adenosine Receptor Antagonists. J. Chem. Inf. Model 2007, 47, 613.